Bullseye Brief

From stone-washed denim in the 80s, to bio-fuels in the 90s, and now a potential cure for Corona, CEO Mark Emalfarb of Dyadic Int'l Inc. (DYAI) has long championed using fast-growing fungal cells to develop biologic solutions at a massive scale... with significant cost-savings. I call it American Ingenuity in the service of humanity. Tune in for: How repurposed fungal cells make drugs. Why companies and countries are signing on. What this means for healthcare in the long run.